October 2013 FDA Recall Drug by Teva Pharmaceuticals Usa
D-392-2014 - Presence of Precipitate; precipitation of drug product

This Class II drug recall was voluntarily initiated by Teva Pharmaceuticals Usa on October 11, 2013 for the product Drug. The FDA reported the reason for recall as presence of precipitate; precipitation of drug product. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-392-2014

Reason for Recall
Presence of Precipitate; precipitation of drug product
Initiated
10-11-2013
Reported
01-08-2014
Quantity
13520 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Teva Pharmaceuticals USA
Daunorubicin Hydrochloride Injection, 20 mg/4 mL (5 mg/mL), 4 mL Single Dose Vial, Rx ONLY, For IV Use Only, Manufactured By: Teva parenteral Medicines, Inc., Irvine, CA NOVAPlus¿¿ labels. NDC 0703-5233-13 (carton), NDC 0703-5233-11 (vial) or NDC 0703-5233-93 (carton), NDC 0703-5233-91 (vial)

Batch or Lot Expiration Information

Lot# Lot number EXP 31314801B, 2/2014; 31314990B, 2/2014; 31314991B, 2/2014; 31315014B, 2/2014; 31315155B, 6/2014; 31315279B, 6/2014; 31315837B, 10/2014; 31315921B, 10/2014; 31316029D, 12/2014; and 31316029C, 12/2014